Bites - Management of Infection Guidance for Primary Care
|Next review: 11/03/2023|
|Copyright© Leeds Teaching Hospitals NHS Trust 2022|
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has recommended restricting the use of fluoroquinolone antibiotics following a review of disabling and potentially long-lasting side effects mainly involving muscles, tendons, bones and the nervous system. This includes a recommendation not to use them for mild or moderately severe infections unless other antibiotics cannot be used (MHRA advice November 2018).
Bites - human and animal
The previous version of this guideline is being reviewed. In the meantime, please refer to NICE guidance :
Human and animal bites: antimicrobial prescribing NG 184
Overview | Human and animal bites: antimicrobial prescribing | Guidance | NICE
|Target patient group:|
|Target professional group(s):||Primary Care Doctors
LHP version 1.0